Moderna, Inc. (MRNA)

Moderna Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	1,944	3,236	6,848	19,263	18,471
Revenue Growth (YoY)	-39.93%	-52.74%	-64.45%	4.29%	2200.25%
Cost of Revenue	868	1,464	4,693	5,416	2,617
Gross Profit	1,076	1,772	2,155	13,847	15,854
Selling, General & Admin	1,018	1,174	1,549	1,132	567
Research & Development	3,132	4,543	4,845	3,295	1,991
Total Operating Expenses	4,150	5,717	6,394	4,427	2,558
Operating Income	-3,074	-3,945	-4,239	9,420	13,296
Interest Income	314	425	421	200	18
Other Non-Operating Income (Expense)	-8	-87	-124	-45	-29
Total Non-Operating Income (Expense)	306	338	297	155	-11
Pretax Income	-2,768	-3,607	-3,942	9,575	13,285
Provision for Income Taxes	54	-46	772	1,213	1,083
Net Income	-2,822	-3,561	-4,714	8,362	12,202
Net Income to Common	-2,822	-3,561	-4,714	8,362	12,202
Net Income Growth	-	-	-	-31.47%	-
Shares Outstanding (Basic)	389	384	382	394	403
Shares Outstanding (Diluted)	389	384	382	416	431
Shares Change (YoY)	1.30%	0.52%	-8.17%	-3.48%	13.12%
EPS (Basic)	-7.26	-9.28	-12.33	21.26	30.31
EPS (Diluted)	-7.26	-9.28	-12.33	20.12	28.29
EPS Growth	-	-	-	-28.88%	-
Shares Outstanding	394	386	382	385	403
Free Cash Flow	-2,065	-4,055	-3,825	4,581	13,336
Free Cash Flow Growth	-	-	-	-65.65%	580.75%
Free Cash Flow Per Share	-5.31	-10.56	-10.01	11.01	30.94
Gross Margin	55.35%	54.76%	31.47%	71.88%	85.83%
Operating Margin	-158.13%	-121.91%	-61.90%	48.90%	71.98%
Profit Margin	-145.17%	-110.04%	-68.84%	43.41%	66.06%
FCF Margin	-106.22%	-125.31%	-55.86%	23.78%	72.20%
EBITDA	-2,859	-3,756	-3,618	9,768	13,528
EBITDA Margin	-147.07%	-116.07%	-52.83%	50.71%	73.24%
EBIT	-3,074	-3,945	-4,239	9,420	13,296
EBIT Margin	-158.13%	-121.91%	-61.90%	48.90%	71.98%
Effective Tax Rate	-1.95%	1.28%	-19.58%	12.67%	8.15%

Updated Feb 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q